President Biden Signs Law Mandating Psychedelic Clinical Trials for Service Members

President Biden has signed the 2024 National Defense Authorization Act into law, and it’s a big win for our service members! The NDDA mandates the Department of Defense to develop a process for service members with PTSD or TBIs to participate in clinical trials using psilocybin, MDMA, ibogaine, and 5-MeO-DMT. This is a significant step forward in providing support and care for those who have served our country. Learn more at Biden Signs Defense Bill Requiring Psychedelics Studies Involving Active Duty Military Service Members – Marijuana Moment.